[1]廖丽萍 周跟东 张晓红.血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展[J].心血管病学进展,2020,(11):1189-1191.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
点击复制

血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年11期
页码:
1189-1191
栏目:
综述
出版日期:
2020-11-25

文章信息/Info

文章编号:
201912024
作者:
廖丽萍1 周跟东2 张晓红2
(1.安徽医科大学研究生院,安徽 合肥 230061 ;2.安徽医科大学第三附属医院心血管内科,安徽 合肥 230061 )
Author(s):
?1.Anhui Medical University Graduate School, Anhui 230061, Hefei, China; 2.Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Anhui 230061, Hefei, China )
关键词:
胰岛素抵抗甘油三酯葡萄糖乘积指数糖尿病心血管系统疾病非酒精性脂肪性肝病
Keywords:
Insulin resistance Triglyceride and glucose index Diabetes Cardiovascular diseases Nonalcoholic fatty liver disease
DOI:
10.16806/j.cnki.issn.1004-3934.2020.11.000
摘要:
随着社会经济的发展和人们生活方式的改变,代谢性疾病的发病率逐年升高,严重威胁着人们的健康。经典的“土壤假说”认为,胰岛素抵抗是代谢性疾病发生和发展的共同病理生理学基础。最新研究显示,血清甘油三酯葡萄糖乘积指数可作为评价胰岛素抵抗简易且经济的指标。现就甘油三酯葡萄糖乘积指数与胰岛素抵抗及相关常见代谢性疾病的研究进展做一综述。
Abstract:
With the development of social economy and the change of people’s lifestyle, the incidence of metabolic diseases is increasing year by year, which is a serious threat to people’s health.The classical “soil hypothesis” holds that insulin resistance is the common pathophysiological basis for the occurrence and development of metabolic diseases. New research shows that the serum triglyceride and glucose index can be a simple and economical indicator of insulin resistance. This article reviews the research progress of triglyceride and g lucose index,insulin resistance and related common metabolic diseases

参考文献/References:

[1]Ceriello A,Motz E.Is oxidative stress the pathogenic mechanism underlying insulin resistance,diabetes,and cardiovascular disease? The common soil hypothesis revisited[J]. Arterioscler Thromb Vasc Biol,2004,24(5):816-823.

[2]Toro-Huamanchumo CJ,Urrunaga-Pastor D,Guarnizo-Poma M,et al. Triglycerides and glucose index as an insulin resistance marker in a sample of healthy adults[J]. Diabetes Metab Syndr,2019,13(1):272-277.

[3]Salazar MR,Carbajal HA,Espeche WG,et al. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals [J]. Nutr Metab Cardiovasc Dis,2017,27(4):366-373.

[4]Aekplakorn W,Chariyalertsak S,Kessomboon P,et al. Prevalence of diabetes and relationship with socioeconomic status in the Thai population:national health examination survey,2004-2014[J]. Diabetes Res ,2018,2018:1654530.

[5]Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet:a new paradigm for the treatment of type 2 diabetes mellitus[J]. Diabetes,2009,58(4):773-795.

[6]Calcaterra V,Montalbano C,de Silvestri A,et al. Triglyceride glucose index as a surrogate measure of insulin sensitivity in a caucasian pediatric population[J]. J Clin Res Pediatr Endocrinol,2019,May 15.DOI:10.4274/jcrpe.galenos.2019.2019.0024.Online ahead of print.

[7]Rodríguez-Morán M,Simental-Mendía LE,Guerrero-Romero F. The triglyceride and glucose index is useful for recognising insulin resistance in children[J]. Acta Paediatr,2017,106(6):979-983.

[8]Omolekulo TE,Michael OS,Olatunji LA. Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid[J].Biomed Pharmacother,2019,110:869-877.

[9]Tirosh A,Shai I,Bitzur R,et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men[J]. Diabetes Care,2008,31(10):2032-2037.

[10]Su WY,Chen SC,Huang YT,et al. Comparison of the effects of fasting glucose, hemoglobin a1c,and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus[J]. Nutrients,2019,11(11):2838.

[11]Lee JW,Lim NK,Park HY. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans[J]. BMC Endocr Disord,2018,18(1):33.

[12]Navarro-González D,Sánchez-??igo L,Pastrana-Delgado J,et al. Triglyceride-glucose index(TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose:the Vascular-Metabolic CUN cohort[J]. Prev Med,2016,86:99-105.

[13]Chamroonkiadtikun P,Ananchaisarp T,Wanichanon W. The triglyceride-glucose index,a predictor of type 2 diabetes development:a retrospective cohort study[J]. Prim Care Diabetes,2020,14(2):161-167.

[14]Tohidi M,Baghbani-Oskouei A,Ahanchi NS,et al. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index,triglycerides/high-density lipoprotein cholesterol,and homeostasis model assessment of insulin resistance:Tehran Lipid and Glucose Study[J]. Acta Diabetol, 2018 ,55:1067-1074.

[15]Han T,Lan L,Qu R,et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension[J]. Hypertension,2017,70(4):703-711.

[16]李莎,熊峰. 胰岛素抵抗与心血管疾病研究进展 [J]. 心血管病学进展,2019,40(9):1307-1311.

[17]Li Y,Yang L,Wang L,et al. Burden of hypertension in China:a nationally representative survey of 174 621 adults[J]. Int J Cardiol,2017,227:516-523.

[18]Xie H,Song J,Sun L,et al. Independent and combined effects of triglyceride-glucose index on prehypertension risk:a cross-sectional survey in China[J]. Hum Hypertens,2020,10:1038.

[19]Simental-Mendía LE,Hernández-Ronquillo G,Gamboa-Gómez CI,et al. The triglycerides and glucose index is associated with elevated blood pressure in apparently healthy children and adolescents[J]. Eur J Pediatr,2019,178(7):1069-1074.

[20]Jian S,Su-Mei N,Xue C,et al. Association and interaction between triglyceride-glucose index and obesity on risk of hypertension in middle-aged and elderly adults[J]. Clin Exp Hypertens,2017,39(8):732-739.

[21]Liu XZ,Fan J,Pan SJ. METS-IR,a novel simple insulin resistance indexes,is associated with hypertension in normal-weight Chinese adults[J]. J Clin Hypertens (Greenwich),2019,21(8):1075-1081.

[22]Gaggini M,Morelli M,Buzzigoli E,et al. Non-alcoholic fatty liver disease(NAFLD) and its connection with insulin resistance,dyslipidemia,atherosclerosis and coronary heart disease[J]. Nutrients,2013,5(5):1544-1560.

[23]Buzzetti E,Pinzani M,Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD)[J]. Metabolism,2016,65(8):1038-1048.

[24]Younossi ZM,Koenig AB,Abdelatif D,et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence,incidence,and outcomes[J]. Hepatology,2016,64(1):73-84.

[25]Zhang S,Du T,Zhang J,et al. The triglyceride and glucose index(TyG) is an effective biomarker to identify nonalcoholic fatty liver disease[J]. Lipids Health Dis,2017,16(1):15.

[26]Kitae A,Hashimoto Y,Hamaguchi M,et al. The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease:a Population-Based Cohort Study[J]. Can J Gastroenterol Hepatol,2019,2019:5121574.

[27]Lee SB,Kim MK,Kang S,et al. Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults[J]. Endocrinol Metab(Seoul),2019,34(2):179-186.

[28]Zheng R,Du Z,Wang M,et al. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease[J]. Lipids Health Dis,2018,17(1):262.

[29] Baumgartl J,Baudler S,Scherner M,et al. Myeloid lineage cell-restricted insulin resistance protects apolipoprotein E-deficient mice against atherosclerosis[J]. Cell Metab,2006,3(4):247-256.

[30]Poon AK,Meyer ML,Tanaka H,et al. Association of insulin resistance,from mid-life to late-life,with aortic stiffness in late-life:the Atherosclerosis Risk in Communities Study[J]. Cardiovasc Diabetol,2020,19(1):11.

[31]Lee SB,Ahn CW,Lee BK,et al. Association between triglyceride glucose index and arterial stiffness in Korean adults[J]. Cardiovasc Diabetol,2018,17(1):41.

[32]Park GM,Cho YR,Won KB,et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors[J]. Lipids Health Dis,2020,19(1):7.

[33]Mao Q,Zhou D,Li Y,et al. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome[J].Dis Markers,2019,2019:6891537.

[34]Luo E,Wang D,Yan G,et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J].Cardiovasc Diabetol,2019,18(1):150.

相似文献/References:

[1]陈炜,许贞蓉.表观遗传学与代谢性心血管疾病的研究进展[J].心血管病学进展,2019,(6):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
 CHEN Wei,XU Zhenrong.Epigenetics and Cardiometabolic Disease[J].Advances in Cardiovascular Diseases,2019,(11):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
[2]占小锋 张长磊 李刚.β肾上腺素受体阻滞剂对甘油三酯代谢的影响及其作用机制的阐述[J].心血管病学进展,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
 ZHAN Xiaofeng,ZHANG Changlei,LI Gang.Effect of -adrenergic Receptor Blockers on Triglyceride Metabolism and Mechanism[J].Advances in Cardiovascular Diseases,2019,(11):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
[3]李莎 熊峰.胰岛素抵抗与心血管疾病研究进展[J].心血管病学进展,2019,(9):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
 Li ShaXiong Feng.Insulin Resistance and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(11):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
 WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(11):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]任蕾 夏芳芳 戴红艳.血管生成素样蛋白6在心血管病方面的研究进展[J].心血管病学进展,2020,(4):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
 REN Lei,XIA FangFang,DAI HongYan.Relationship Between ANGPTL6 and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(11):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
[6]杨晓倩 秦莉 张艺文 童兰 汪汉.糖皮质激素与心血管疾病[J].心血管病学进展,2020,(4):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
 YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Glucocorticoid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(11):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
[7]樊德慧 金娟 韩宇博 田苗 刘莉.利钠肽与代谢综合征的研究进展[J].心血管病学进展,2020,(10):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
 FAN Dehui,JIN Juan,HAN Yubo,et al.Research Progress of Natriuretic Peptide and Metabolic Syndrome[J].Advances in Cardiovascular Diseases,2020,(11):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
[8]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
 WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(11):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[9]谭思华 周晓莉.非酒精性脂肪肝与冠状动脉粥样硬化及炎症的研究进展[J].心血管病学进展,2023,(5):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
 TAN Sihua,ZHOU Xiaoli.Association of Non-Alcoholic Fatty Liver Disease with Coronary Atherosclerosis and Inflammation[J].Advances in Cardiovascular Diseases,2023,(11):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
[10]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
 Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(11):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
[11]蔡薇 杨堰焯 刘昊凌.甘油三酯葡萄糖乘积指数与糖尿病血管病变的研究进展[J].心血管病学进展,2022,(3):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 CAI Wei,YANG Yanzhuo,LIU Haoling.Triglyceride-Glucose Index and Diabetic Vascular Disease[J].Advances in Cardiovascular Diseases,2022,(11):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[12]魏罗嫚,杨玉亭,和丽丽,等.甘油三酯葡萄糖乘积指数在心力衰竭中的研究进展[J].心血管病学进展,2023,(8):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]
 WEI Luoman,YANG Yuting,HE Lili,et al.Advances of Triglyceride Glucose Index in Heart Failure[J].Advances in Cardiovascular Diseases,2023,(11):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]

更新日期/Last Update: 2021-02-04